Dexco S.A.

BOVESPA:DXCO3 Voorraadrapport

Marktkapitalisatie: R$4.9b

Dexco Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Dexco heeft een totaal eigen vermogen van R$6.7B en een totale schuld van R$7.1B, wat de schuld-eigenvermogensverhouding op 105.8% brengt. De totale activa en totale passiva bedragen respectievelijk R$18.6B en R$11.8B. De EBIT Dexco is R$898.3M waardoor de rentedekking 0.9 is. Het heeft contanten en kortetermijnbeleggingen van R$2.2B.

Belangrijke informatie

105.8%

Verhouding schuld/eigen vermogen

R$7.12b

Schuld

Rente dekkingsratio0.9x
ContantR$2.15b
AandelenR$6.73b
Totaal verplichtingenR$11.84b
Totaal activaR$18.57b

Recente financiële gezondheidsupdates

Is Dexco (BVMF:DXCO3) A Risky Investment?

Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Is Dexco (BVMF:DXCO3) A Risky Investment?

Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

May 31
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Feb 13
We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Nov 13
We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Recent updates

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Is Dexco (BVMF:DXCO3) A Risky Investment?

Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Is Dexco (BVMF:DXCO3) A Risky Investment?

Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Jun 22
Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

May 31
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)

Mar 10
We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Feb 13
We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger

Dec 02
Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Nov 13
We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?

Oct 11
Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?

Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist

Aug 20
Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Aug 05
We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?

Jun 10
Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?

There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital

May 11
There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital

Is Dexco (BVMF:DXCO3) Using Too Much Debt?

Apr 27
Is Dexco (BVMF:DXCO3) Using Too Much Debt?

Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock

Mar 15
Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Feb 24
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

The Return Trends At Dexco (BVMF:DXCO3) Look Promising

Feb 04
The Return Trends At Dexco (BVMF:DXCO3) Look Promising

Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching

Dec 08
Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching

These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely

Nov 20
These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely

Dexco (BVMF:DXCO3) Is Doing The Right Things To Multiply Its Share Price

Oct 25
Dexco (BVMF:DXCO3) Is Doing The Right Things To Multiply Its Share Price

Does Dexco (BVMF:DXCO3) Deserve A Spot On Your Watchlist?

Sep 02
Does Dexco (BVMF:DXCO3) Deserve A Spot On Your Watchlist?

Duratex (BVMF:DTEX3) Has A Rock Solid Balance Sheet

Aug 18
Duratex (BVMF:DTEX3) Has A Rock Solid Balance Sheet

Is It Too Late To Consider Buying Duratex S.A. (BVMF:DTEX3)?

Aug 05
Is It Too Late To Consider Buying Duratex S.A. (BVMF:DTEX3)?

Duratex (BVMF:DTEX3) Shareholders Will Want The ROCE Trajectory To Continue

Jul 21
Duratex (BVMF:DTEX3) Shareholders Will Want The ROCE Trajectory To Continue

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( R$5.5B ) DXCO3 } overtreffen de korte termijn passiva ( R$3.7B ).

Langlopende schulden: De kortetermijnactiva van DXCO3 ( R$5.5B ) dekken de langetermijnschulden ( R$8.2B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 73.8% ) DXCO3 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van DXCO3 is de afgelopen 5 jaar gestegen van 67.3% naar 105.8%.

Schuldendekking: De schuld van DXCO3 wordt goed gedekt door de operationele kasstroom ( 20.8% ).

Rentedekking: De rentebetalingen van DXCO3 op haar schulden worden niet goed gedekt door EBIT ( 0.9 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2024/12/25 18:52
Aandelenkoers aan het einde van de dag2024/12/23 00:00
Inkomsten2024/09/30
Jaarlijkse inkomsten2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Dexco S.A. wordt gevolgd door 20 analisten. 9 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Leonardo NeratikaBofA Global Research
Guilherme RositoBofA Global Research
Thiago LofiegoBradesco S.A. Corretora de Títulos e Valores Mobiliários